Literature DB >> 1654136

Neuroendocrine effects of diazepam in panic and generalized anxiety disorders.

P P Roy-Byrne1, D S Cowley, D Hommer, J Ritchie, D Greenblatt, C Nemeroff.   

Abstract

The adrenocorticotropic hormone (ACTH), cortisol, and growth hormone responses to four consecutive, logarithmically increasing doses of intravenous diazepam compared with placebo given at 15-min intervals were examined in patients with panic disorder (n = 13), generalized anxiety disorder (n = 8), and healthy controls (n = 13). Diazepam caused dose-dependent decreases in cortisol and increases in GH and dose-independent decreases in ACTH. There were no patient-control differences, possibly due to either the small sample size of the experimental paradigm, which tested subjects in an upright, sitting position in mildly arousing circumstances.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1654136     DOI: 10.1016/0006-3223(91)90072-t

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  8 in total

Review 1.  Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.

Authors:  Borwin Bandelow; David Baldwin; Marianna Abelli; Blanca Bolea-Alamanac; Michel Bourin; Samuel R Chamberlain; Eduardo Cinosi; Simon Davies; Katharina Domschke; Naomi Fineberg; Edna Grünblatt; Marek Jarema; Yong-Ku Kim; Eduard Maron; Vasileios Masdrakis; Olya Mikova; David Nutt; Stefano Pallanti; Stefano Pini; Andreas Ströhle; Florence Thibaut; Matilde M Vaghi; Eunsoo Won; Dirk Wedekind; Adam Wichniak; Jade Woolley; Peter Zwanzger; Peter Riederer
Journal:  World J Biol Psychiatry       Date:  2016-07-15       Impact factor: 4.132

2.  Combined Pharmacotherapy and Cognitive-Behavioral Therapy for Anxiety Disorders: Medication Effects, Glucocorticoids, and Attenuated Treatment Outcomes.

Authors:  Michael W Otto; R Kathryn McHugh; Kathleen M Kantak
Journal:  Clin Psychol (New York)       Date:  2010-06-08

Review 3.  Selective GABAergic treatment for panic? Investigations in experimental panic induction and panic disorder.

Authors:  Peter Zwanzger; Rainer Rupprecht
Journal:  J Psychiatry Neurosci       Date:  2005-05       Impact factor: 6.186

4.  Dose-dependent effects of intravenous alprazolam on neuroendocrine, biochemical, cardiovascular, and behavioral parameters in humans.

Authors:  O T Osman; J K Hsiao; W Z Potter
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 5.  Benzodiazepines and anterior pituitary function.

Authors:  E Arvat; R Giordano; S Grottoli; E Ghigo
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

6.  Cortisol response to diazepam: its relationship to age, dose, duration of treatment, and presence of generalized anxiety disorder.

Authors:  Nunzio Pomara; Lisa M Willoughby; John J Sidtis; Thomas B Cooper; David J Greenblatt
Journal:  Psychopharmacology (Berl)       Date:  2004-08-27       Impact factor: 4.530

7.  Effect of acute and chronic benzodiazepines on plasma GABA in anxious patients and controls.

Authors:  P P Roy-Byrne; D S Cowley; D Hommer; D J Greenblatt; G L Kramer; F Petty
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  Assessment of single-dose benzodiazepines on insulin secretion, insulin sensitivity and glucose effectiveness in healthy volunteers: a double-blind, placebo-controlled, randomized cross-over trial [ISRCTN08745124].

Authors:  Hugues Chevassus; Isabelle Mourand; Nathalie Molinier; Bruno Lacarelle; Jean-Frédéric Brun; Pierre Petit
Journal:  BMC Clin Pharmacol       Date:  2004-03-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.